1. Advances in research of nephrotoxicity and toxic antagonism of ochratoxin A
   Tao Zhao et al, 2017, Toxin Reviews CrossRef
2. Implementation of Proteomics Biomarkers in Nephrology: From Animal Models to Human Application?
   Julie Klein et al, 2019, PROTEOMICS – Clinical Applications CrossRef
3. New Evidence on Regucalcin, Body Composition, and Walking Ability Adaptations to Multicomponent Exercise Training in Functionally Limited and Frail Older Adults
   Jorge Pérez-Gómez et al, 2021, International Journal of Environmental Research and Public Health CrossRef
4. Prolonged survival of renal cancer patients is concomitant with a higher regucalcin gene expression in tumor tissues: Overexpression of regucalcin suppresses the growth of human renal cell carcinoma cells in vitro
   Masayoshi Yamaguchi et al, 2018, International Journal of Oncology CrossRef
5. Regucalcin enhances adipocyte differentiation and attenuates inflammation in 3T3‐L1 cells
   Tomiyasu Murata et al, 2020, FEBS Open Bio CrossRef
6. Extracellular Regucalcin: A Potent Suppressor in the Cancer Cell Microenvironment
   Masayoshi Yamaguchi, 2025, Cancers CrossRef
7. The protective effect of allium cepa against ethylene glycol-induced kidney stones in rats
   Reham M. Wahid et al, 2023, Heliyon CrossRef
8. Proteomics and Advancements in Urinary Biomarkers of Diabetics Kidney Disease
   M.L. Merchant et al, 2017, Biomarkers of Kidney Disease CrossRef
9. Uroplakin 1a Interacts with Regucalcin and Proteasome Subunit Beta 1
   Suresh Babu Munipalli et al, 2023, Reproductive Sciences CrossRef
10. Regucalcin Is a Potential Regulator in Human Cancer: Aiming to Expand into Cancer Therapy
    Masayoshi Yamaguchi, 2023, Cancers CrossRef